Inari Medical, Inc. (NARI)
| Market Cap | 3.88B |
| Revenue (ttm) | 242.38M |
| Net Income (ttm) | 15.72M |
| Shares Out | 50.20M |
| EPS (ttm) | 0.28 |
| PE Ratio | 272.36 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 395,192 |
| Open | 76.10 |
| Previous Close | 77.89 |
| Day's Range | 75.00 - 79.27 |
| 52-Week Range | 68.44 - 127.42 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 121.00 (+56.4%) |
| Earnings Date | Nov 9, 2021 |
About NARI
Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It offers ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.
Financial Performance
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for Inari Medical stock is "Strong Buy." The 12-month stock price forecast is 121.00, which is an increase of 56.43% from the latest price.
News
Inari Medical (NARI) Posts Solid Preliminary Q4, FY2021 Revenues
Inari Medical (NARI) posts solid fourth-quarter and full-year 2021 revenue data, courtesy of resilience shown in the face of the COVID-19 induced challenges.
Inari Medical Reports Solid Preliminary Q4, FY21 Sales
Inari Medical Inc (NASDAQ: NARI) expects Q4 FY21 sales of $82.8 million - $83.3 million, up 14% sequentially and 71% year-over-year (at the midpoint of the range), beating the consensus of $73.16 millio...
Inari Medical Reports Preliminary Fourth Quarter 2021 Revenue
IRVINE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...
Inari Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference
IRVINE, Calif., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...
3 High-Growth Stocks Wall Street Thinks Could Rise 50% or More
Huge gains could be up ahead if the rest of the market sees these stocks in the same light as investment bank analysts.
3 COVID-19 Stocks That Should Beat the Market in 2022
Our Foolish roundtable has three stocks to invest in as we enter our third year of the COVID pandemic.
3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now
It doesn't take a lot to own a piece of these rapidly growing healthcare businesses.
New Strong Sell Stocks for November 10th
AZN, GOLD, NARI, KOP, and TCEHY have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2021.
Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates
Inari Medical's (NARI) third-quarter results benefit from new product launches and continued U.S. commercial expansion.
Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 45.45% and 17.30%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: Inari Medical Q3 Earnings
Inari Medical (NASDAQ:NARI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 04:01 PM. Here's what investors need to know about the announcement.
Inari Medical Reports Third Quarter 2021 Financial Results
IRVINE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...
Earnings Preview: Inari Medical, Inc. (NARI) Q3 Earnings Expected to Decline
Inari Medical, Inc. (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inari Medical Announces 6-month FLASH Registry Interim Data Demonstrating Benefits of Lytic-Free Mechanical Thrombect...
IRVINE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...
Inari Medical to Announce Third Quarter 2021 Financial Results
IRVINE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the lives ...
Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund
The Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) disclosed its portfolio for the third quarter of the year earlier this week.
3 Under-the-Radar COVID Stocks
Some COVID-19 stocks are pretty famous. But other lesser-known names are flying high, too.
Inari Medical Announces Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System in Pulmon...
IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffer...
President And CEO Of Inari Medical Makes $2.4M Sale
William Hoffman, President And CEO at Inari Medical (NASDAQ:NARI), made a large insider sell on October 7, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exch...
Reasons to Hold on to Inari Medical (NARI) Stock For Now
Investors continue to be optimistic about Inari Medical (NARI) owing to its focus on understanding the venous system and its commitment toward patient care.
Inari Medical Appoints Dana G. Mead, Jr. to Board of Directors
IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffe...
3 Top Healthcare Stocks You Can Buy for $100 or Less
It doesn't take a lot of upfront cash to add one of these stocks to your portfolio.
American Airlines Group Inc Ranked Among Today's Top Shorts As COVID-19 Concerns Continue To Rise
The Dow rose about 210 points, the S&P 500 rebounded by 0.6%, and the Nasdaq added another 0.6%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.
Why Is Inari Medical, Inc. (NARI) Up 8.8% Since Last Earnings Report?
Inari Medical, Inc. (NARI) reported earnings 30 days ago. What's next for the stock?
3 High-Growth Healthcare Stocks to Buy in September
All three are rapidly expanding into their own corners of America's $4 trillion per year healthcare sector.